The indolent nature of type 1 gastric neuroendocrine tumors under 1 cm
Digestive and Liver Disease · 2026-01 · 58 (1) · 119-124
DOI: 10.1016/j.dld.2025.09.011 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Digestive and Liver Disease, 2026-01. Verfasst von Elisabetta Dell'Unto und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University of Rome, Digestive Disease Unit, ENETS Center of Excellence, …. Hauptthemen laut MEDLINE: Stomach Neoplasms, Neuroendocrine Tumors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Type 1 gastric neuroendocrine tumors (T1-gNETs) are typically indolent. Current guidelines suggest endoscopic surveillance for lesions ≤10 mm, mainly based on expert consensus. AIM: To evaluate outcomes in patients with T1-gNETs ≤10 mm managed by endoscopic surveillance. METHODS: This dual-center retrospective study (2000-2023) included patients from two Western ENETS Centers of Excellence with T1-gNETs ≤10 mm under surveillance. Primary endpoints were disease progression rate and progression-free survival (PFS); p < 0.05 was considered significant. RESULTS: A total of 125 patients (66.4 % female; median age 59.5 years) with a median tumor size of 3 mm were analyzed. Most tumors were G1 (92.8 %), and 75.2 % had ≤5 lesions. Over a median follow-up of 72 months, progression occurred in 5 patients (4 %), with no metastases. Low-grade dysplasia was found in 2.4 % and early gastric cancer in 1.6 %. Eleven patients (8.8 %) died, none from tumor-related causes. Restricted mean survival time was 266.5 months. The 5-year PFS rate was 97.8 %. Having ≤5 lesions was significantly associated with lower progression risk (HR = 0.14, 95 % CI: 0.014-0.76, p = 0.022). CONCLUSIONS: T1-gNETs ≤10 mm show low progression risk and can be safely managed with lifelong surveillance. In patients with solitary or few lesions, extended intervals may be appropriate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University of Rome, Digestive Disease Unit, ENETS Center of Excellence, Sant'Andrea University Hospital, Via di Grottarossa 1035-1039, 00189,…
- Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, Pond Street, London NW3 2QG, United Kingdom.
- Royal Free Unit for Endoscopy, The Royal Free Hospital, University College London Institute for Liver and Digestive Health, Pond Street, London NW3 2QG, United Kingdom.
- Department of Cellular Pathology, Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, United Kingdom.
- Institute of Cognitive Sciences and Technologies - National Research Council of Italy (ISTC-CNR), Via San Martino della Battaglia 44, 00185, Rome, Italy.
Zitieren
APA
Dell'Unto, E., Mandair, D., Riding, G., Rimondi, A., Rinzivillo, M., Esposito, G., Luong, T. V., Lahner, E., Watkins, J., Annibale, B., Murino, A., Despott, E. J., Caplin, M., Marini, M., Panzuto, F., & Toumpanakis, C. (2026). The indolent nature of type 1 gastric neuroendocrine tumors under 1 cm. Digestive and Liver Disease, 58(1), 119-124. https://doi.org/10.1016/j.dld.2025.09.011
Vancouver
Dell'Unto E, Mandair D, Riding G, Rimondi A, Rinzivillo M, Esposito G, et al. The indolent nature of type 1 gastric neuroendocrine tumors under 1 cm. Digestive and Liver Disease. 2026;58(1):119-124. doi:10.1016/j.dld.2025.09.011
BibTeX
@article{DellUnto2026,
author = {Dell'Unto, Elisabetta and Mandair, Dalvinder and Riding, George and Rimondi, Alessandro and Rinzivillo, Maria and Esposito, Gianluca and Luong, Tu Vinh and Lahner, Edith and Watkins, Jennifer and Annibale, Bruno and Murino, Alberto and Despott, Edward John and Caplin, Martyn and Marini, Marco and Panzuto, Francesco and Toumpanakis, Christos},
title = {The indolent nature of type 1 gastric neuroendocrine tumors under 1 cm},
journal = {Digestive and Liver Disease},
year = {2026},
volume = {58},
number = {1},
pages = {119--124},
doi = {10.1016/j.dld.2025.09.011}
}
EUVIMED